Division of Nutritional Sciences, Cornell University, Ithaca, NY.
Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
J Nutr. 2018 Jun 1;148(6):868-875. doi: 10.1093/jn/nxy043.
Interpretation of serum vitamin D biomarkers across pregnancy is complex due to limited understanding of pregnancy adaptations in vitamin D metabolism. During pregnancy, both gestational age and serum 25-hydroxyvitamin D [25(OH)D] concentrations may influence the concentrations of 1,25-dihydroxyvitamin D [1,25(OH)2D], 24,25-dihydroxyvitamin D [24,25(OH)2D], and parathyroid hormone (PTH).
We aimed to identify predictors of change in serum 25(OH)D across gestation in pregnant adolescents and to assess the contribution made by cholecalciferol (vitamin D3) supplementation. We sought to determine whether gestational age and 25(OH)D concentration interacted to affect serum 1,25(OH)2D, 24,25(OH)2D, or PTH.
Pregnant adolescents (n = 78, 59% African American, mean ± SD age: 17 ± 1 y) living in Rochester, NY (latitude 43°N) were supplemented with 200 IU or 2000 IU vitamin D3/d and allowed to continue their daily prenatal supplement that contained 400 IU vitamin D3. Serum was collected at study entry (18 ± 5 wk of gestation), halfway through study participation, and at delivery (40 ± 2 wk). Serum concentrations of the biochemical markers were modeled with linear mixed-effects regression models.
Vitamin D3 supplement intake and season of delivery determined change in 25(OH)D across pregnancy. Fall-winter delivery was associated with a decline in 25(OH)D unless vitamin D3 supplement intake was >872 IU/d. The interaction of gestational age and 25(OH)D affected 24,25(OH)2D concentrations. For a given 25(OH)D concentration, model-predicted serum 24,25(OH)2D increased across gestation except when 25(OH)D was <13 ng/mL. Below this threshold, 24,25(OH)2D was predicted to decline over time. Mean serum 1,25(OH)2D was elevated (>100 pg/mL) throughout the study.
Our results suggest that when maternal serum 25(OH)D was low, its catabolism into 24,25(OH)2D decreased or remained stable as pregnancy progressed in order to maintain persistently elevated serum 1,25(OH)2D. Furthermore, in adolescents living at latitude 43°N, standard prenatal supplementation did not prevent a seasonal decline in 25(OH)D during pregnancy. This study was registered at clinicaltrials.gov as NCT01815047.
由于对妊娠期间维生素 D 代谢的适应性了解有限,因此妊娠期间血清维生素 D 生物标志物的解读较为复杂。在妊娠期间,妊娠龄和血清 25-羟维生素 D [25(OH)D]浓度可能都会影响 1,25-二羟维生素 D [1,25(OH)2D]、24,25-二羟维生素 D [24,25(OH)2D]和甲状旁腺激素 (PTH)的浓度。
本研究旨在确定青少年孕妇血清 25(OH)D 浓度随妊娠变化的预测因素,并评估胆钙化醇(维生素 D3)补充的作用。我们试图确定妊娠龄和 25(OH)D 浓度是否会相互作用,从而影响血清 1,25(OH)2D、24,25(OH)2D 或 PTH。
居住在纽约罗彻斯特(北纬 43°)的 78 名孕妇(59%为非裔美国人,平均年龄 ± 标准差:17±1 岁)接受 200 IU 或 2000 IU 维生素 D3/d 补充剂,并允许其继续服用含有 400 IU 维生素 D3 的每日产前补充剂。在研究开始时(妊娠 18±5 周)、研究中期和分娩时(妊娠 40±2 周)采集血清。使用线性混合效应回归模型对生化标志物的血清浓度进行建模。
维生素 D3 补充摄入量和分娩季节决定了妊娠期间 25(OH)D 的变化。秋季和冬季分娩会导致 25(OH)D 下降,除非维生素 D3 补充摄入量>872 IU/d。妊娠龄和 25(OH)D 的相互作用影响 24,25(OH)2D 浓度。在给定的 25(OH)D 浓度下,除了 25(OH)D<13ng/mL 时,模型预测的血清 24,25(OH)2D 随妊娠进展而增加。在此阈值以下,24,25(OH)2D 预计会随时间下降。整个研究过程中,模型预测血清 1,25(OH)2D 水平升高(>100pg/mL)。
我们的结果表明,当母体血清 25(OH)D 较低时,其代谢为 24,25(OH)2D 的过程减少或保持稳定,以维持持续升高的血清 1,25(OH)2D 水平。此外,在居住于北纬 43°的青少年中,标准产前补充剂并不能防止妊娠期间血清 25(OH)D 季节性下降。本研究在 clinicaltrials.gov 注册,注册号为 NCT01815047。